Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Aug;55(3):255-62.
doi: 10.1037/a0020492.

Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis

Affiliations
Randomized Controlled Trial

Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis

Michelle Nicole Burns et al. Rehabil Psychol. 2010 Aug.

Abstract

Objective: Anxiety is highly comorbid with depression, but little is known about the impact of anxiety disorders on the effectiveness of empirically supported psychotherapies for depression. We examined such outcomes for people with Multiple Sclerosis (MS) and depression, with versus without comorbid anxiety disorders.

Design: Participants with MS (N = 102) received 16 weeks of telephone-administered psychotherapy for depression and were followed for one year post-treatment.

Results: Participants with comorbid anxiety disorders improved to a similar degree during treatment as those without anxiety disorders. Outcomes during follow-up were mixed, and thus we divided the anxiety diagnoses into distress and fear disorders. The distress disorder (GAD) was associated with elevated anxiety symptoms during and after treatment. In contrast, fear disorders (i.e., panic disorder, agoraphobia, social phobia, specific phobia) were linked to depression, specifically during follow-up, across 3 different measures.

Conclusions: People with GAD receiving treatment for depression may benefit from additional services targeting anxiety more specifically, while those with comorbid fear disorders may benefit from services targeting maintenance of gains after treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Major Depressive Disorder (MDD) diagnostic frequency and raw Beck Depression Inventory-II (BDI-II) scores over time, split by baseline fear disorder comorbidity.
Figure 2
Figure 2
Raw Hamilton Depression Rating Scale (HDRS) and Hospital Anxiety and Depression Scale, Anxiety Scale (HADS-A) scores over time, split respectively by baseline fear and distress disorder (GAD) comorbidity.

References

    1. Allen L, McHugh R, Barlow D. Emotional disorders: A unified protocol. In: Barlow DH, editor. Clinical handbook of psychological disorders: A step-by-step treatment manual. Guilford Press; New York: 2008. pp. 216–249.
    1. Barlow D, Allen L, Choate M. Toward a unified treatment for emotional disorders. Behavior Therapy. 2004;35:205–230. - PubMed
    1. Beck A, Steer R, Brown G. Beck Depression Inventory: Second Edition: Manual. Psychological Corp.; San Antonio, TX: 1996.
    1. Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, Myhr K. Depression and anxiety amongst multiple sclerosis patients. European Journal of Neurology. 2008;15:239–245. - PubMed
    1. Brown C, Schulberg H, Madonia M, Shear M, Houck P. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. American Journal of Psychiatry. 1996;153:1293–1300. - PubMed

Publication types